PMDAsafety guidance54% confidence
[IBENTO][IBENTO]PMDA-ATC Blood Products Seminar 2026 for PPWG Applications open.
Source: PMDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (copd) as Teva.
Regulatory Analysis
PMDA document relevant to the signal.
Supporting Context
- Therapeutic area
- Respiratory · Asthma/COPD
- Sub-indication
- COPD
Related signal: FDA Accepts Application for Budesonide and Formoterol Fumarate Dihydrate